Interestingly, whereas some neurodegenerative disorders such as MS, PD and AD involve the participation of inflammatory CD4+ T-cells 'naturally', the physiopathology of other neurodegenerative diseases, such as ALS, is associated with the participation of anti-inflammatory CD4+ T-cells that delay the neurodegenerative process. This evidence concerns the gene CD4 and Parkinson disease.